In a 6-to-3 ruling, the US Supreme Court has struck down a highly controversial Vermont law that restricts the sale of prescription drug info identifying prescribers and patients for commercial marketing purposes. The practice is known in the pharma world as data mining and has been growing for the past two decades, ever since data was gathered by market research firms. However, data mining has also sparked heated arguments over free speech, health care costs and information privacy . . . .